Aralez Pharmaceuticals Inc. – Announces Pair of Asset Sales Valued at $240 million

September 19, 2018 – Aralez Pharmaceuticals Inc. (“Aralez”) announced that it entered into purchase agreements with two separate stalking horse purchasers to sell their main operating businesses: the first is an agreement to sell its VIMOVO® royalties and Canadian operations to Nuvo Pharmaceuticals Inc. (“Nuvo”) in a transaction valued at $110 million and the second…